Griffin Daniel, Liu Xiufang, Pru Cindy, Pru James K, Peluso John J
Department of Obstetrics and Gynecology, University of Connecticut Health Center, Farmington, Connecticut.
Department of Cell Biology, University of Connecticut Health Center, Farmington, Connecticut.
Biol Reprod. 2014 Aug;91(2):36. doi: 10.1095/biolreprod.114.117481. Epub 2014 Jul 2.
Progesterone receptor membrane component 2 (Pgrmc2) mRNA was detected in the immature rat ovary. By 48 h after eCG, Pgrmc2 mRNA levels decreased by 40% and were maintained at 48 h post-hCG. Immunohistochemical studies detected PGRMC2 in oocytes and ovarian surface epithelial, interstitial, thecal, granulosa, and luteal cells. PGRMC2 was also present in spontaneously immortalized granulosa cells, localizing to the cytoplasm of interphase cells and apparently to the mitotic spindle of cells in metaphase. Interestingly, PGRMC2 levels appeared to decrease during the G1 stage of the cell cycle. Moreover, overexpression of PGRMC2 suppressed entry into the cell cycle, possibly by binding the p58 form of cyclin dependent kinase 11b. Conversely, Pgrmc2 small interfering RNA (siRNA) treatment increased the percentage of cells in G1 and M stage but did not increase the number of cells, which was likely due to an increase in apoptosis. Depleting PGRMC2 did not inhibit cellular (3)H-progesterone binding, but attenuated the ability of progesterone to suppress mitosis and apoptosis. Taken together these studies suggest that PGRMC2 affects granulosa cell mitosis by acting at two specific stages of the cell cycle. First, PGRMC2 regulates the progression from the G0 into the G1 stage of the cell cycle. Second, PGRMC2 appears to localize to the mitotic spindle, where it likely promotes the final stages of mitosis. Finally, siRNA knockdown studies indicate that PGRMC2 is required for progesterone to slow the rate of granulosa cell mitosis and apoptosis. These findings support a role for PGRMC2 in ovarian follicle development.
在未成熟大鼠卵巢中检测到孕激素受体膜组分2(Pgrmc2)mRNA。在注射eCG后48小时,Pgrmc2 mRNA水平下降了40%,并在注射hCG后48小时维持该水平。免疫组织化学研究在卵母细胞、卵巢表面上皮细胞、间质细胞、卵泡膜细胞、颗粒细胞和黄体细胞中检测到了PGRMC2。PGRMC2也存在于自发永生化的颗粒细胞中,定位于间期细胞的细胞质中,在中期细胞中明显定位于有丝分裂纺锤体。有趣的是,PGRMC2水平在细胞周期的G1期似乎下降。此外,PGRMC2的过表达抑制细胞进入细胞周期,可能是通过结合细胞周期蛋白依赖性激酶11b的p58形式来实现。相反,用Pgrmc2小干扰RNA(siRNA)处理增加了处于G1期和M期的细胞百分比,但没有增加细胞数量,这可能是由于细胞凋亡增加所致。耗尽PGRMC2并不抑制细胞对(3)H-孕酮的结合,但减弱了孕酮抑制有丝分裂和细胞凋亡的能力。综合这些研究表明,PGRMC2通过作用于细胞周期的两个特定阶段来影响颗粒细胞的有丝分裂。第一,PGRMC2调节从G0期进入细胞周期G1期的进程。第二,PGRMC2似乎定位于有丝分裂纺锤体,在那里它可能促进有丝分裂的最后阶段。最后,siRNA敲低研究表明,孕酮减缓颗粒细胞有丝分裂和细胞凋亡速率需要PGRMC2。这些发现支持了PGRMC2在卵巢卵泡发育中的作用。